Survivorship in adults with malignant brain and other central nervous system tumor from 2000

Survivorship in adults with malignant brain and other central nervous system tumor from 2000–2014

Published:2018-11 Issue:suppl_7 Volume:20 Page:vii6-vii16
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Gittleman Haley¹²,Boscia Alexander¹²,Ostrom Quinn T¹³,Truitt Gabrielle¹²,Fritz Yi²,Kruchko Carol¹,Barnholtz-Sloan Jill S¹²

Affiliation:

1. Central Brain Tumor Registry of the United States, Hinsdale, Illinois

2. Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio

3. Department of Medicine, Section of Epidemiology and Population Sciences, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas

Funder

Cancer Prevention and Research Institute of Texas

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/20/suppl_7/vii6/26534013/noy090.pdf

Reference22 articles.

1. The 2016 World Health Organization classification of tumors of the central nervous system: a summary;Louis;Acta Neuropathol,2016

2. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014;Ostrom;Neuro Oncol,2017

3. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas;Ohgaki;J Neuropathol Exp Neurol,2005

4. IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas;Olar;Acta Neuropathol,2015

5. IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO;Reuss;Acta Neuropathol,2015

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gender differences in gliomas: From epidemiological trends to changes at the hormonal and molecular levels;Cancer Letters;2024-08

2. New insights into targeted therapy of glioblastoma using smart nanoparticles;Cancer Cell International;2024-05-07

3. Availability and utilization of molecular testing for primary central nervous system tumors among US hospitals;Journal of Neuropathology & Experimental Neurology;2024-04-30

4. A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1;Clinical Cancer Research;2024-04-17

5. Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective study;Cancer Letters;2024-04